The health financing agenda over the past year was dominated by the PM/Cabinet’s decision to develop a Health Insurance (HI) policy and scheme; time and energy have been focussed on HI, while the Health Financing Strategy (HFS) process eventually stalled or never really took off; not unexpectedly, the evaluation team of the JAR 2013 confirms the limited HFS progress. While the analytic work supported by various EDPs has contributed to a better understanding of the HF situation in view of strategic options, the current focus on HI is based on a more political decision than guided by sound technical evidence regarding possible gains, feasibility and sustainability.
In this context, the CD participated in a WHO/WB mission to discuss the role and content of the HI policy. See CD report below for further details…
